Carson Wealth (CWM LLC)
YMAB

Carson Wealth (CWM LLC)’s Y-mAbs Therapeutics YMAB Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio YMAB Stock Details YMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,121
Closed -$32K – 5586
2025
Q2 		$32K Buy
7,121
+4,771
+203% +$21.4K ﹤0.01% 3622
2025
Q1 		$10K Buy
2,350
+2,282
+3,356% +$13.2K ﹤0.01% 4122
2024
Q4 		$1K Sell
68
-7
-9% -$85 ﹤0.01% 4838
2024
Q3 		$1K Buy
75
+8
+12% +$101 ﹤0.01% 4747
2024
Q2 		$1K Buy
67
+1
+2% +$14 ﹤0.01% 4522
2024
Q1 		$1K Buy
66
+1
+2% +$13 ﹤0.01% 4246
2023
Q4 		$0 Hold
65
– – ﹤0.01% 4565
2023
Q3 		$0 Buy
+65
New +$379 ﹤0.01% 4564

Other funds holding YMAB

BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Carson Wealth (CWM LLC)'s YMAB Position: Q3 2025 in Review

Carson Wealth (CWM LLC) sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 7,121 shares — an estimated $32K sold.

Carson Wealth (CWM LLC) first reported a position in YMAB in Q3 2023 and held it in 8 quarters. The position peaked at $32K in Q2 2025. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • Carson Wealth (CWM LLC) reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 7,121 Y-mAbs Therapeutics shares in Q3 2025, an estimated $32K.
  • Carson Wealth (CWM LLC) first reported a position in Y-mAbs Therapeutics in Q3 2023 and held it in 8 quarters.
  • Carson Wealth (CWM LLC)'s Y-mAbs Therapeutics position peaked at $32K in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q3 2025, filed 15 Oct 2025.